Cargando…
Genomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancers
BACKGROUND: Alterations in epigenetic marks, including methylation or acetylation, are common in human cancers. For many epigenetic pathways, however, direct measures of activity are unknown, making their role in various cancers difficult to assess. Gene expression signatures facilitate the examinat...
Autores principales: | Cohen, Adam L, Piccolo, Stephen R, Cheng, Luis, Soldi, Rafaella, Han, Bing, Johnson, W Evan, Bild, Andrea H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850967/ https://www.ncbi.nlm.nih.gov/pubmed/24079712 http://dx.doi.org/10.1186/1755-8794-6-35 |
Ejemplares similares
-
Classifying cancer genome aberrations by their mutually exclusive effects on transcription
por: Dayton, Jonathan B., et al.
Publicado: (2017) -
Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC
por: Schade, Amy E., et al.
Publicado: (2023) -
Algorithms for mutual exclusion /
por: Raynal, Michel
Publicado: (1986) -
Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations
por: Babur, Özgün, et al.
Publicado: (2015) -
New epigenetic pathway for stemness maintenance mediated by the histone methyltransferase Ezh1
por: Hidalgo, Isabel, et al.
Publicado: (2013)